PBMs Under Fire at Senate Hearing
Expert witnesses call for strong consumer protection, federal regulation
The role of pharmacy benefit managers (PBMs) in the drug supply chain and whether "anti-competitive" practices are driving up healthcare costs was scrutinized by the Senate on Thursday.
PBMs are just one player in a "broken supply chain" explained Richard Blumenthal (D-Conn.), during a Thursday hearing of the Senate Subcommittee for the Committee on Commerce, Science, and Transportation.
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!